(Q37108845)

18 August 2017

1 reference

title

Innate immunity and alcoholic liver fibrosis (English)

1 reference

18 August 2017

Won-Il Jeong

1

1 reference

PMC publication ID

2737176

18 August 2017

Bin Gao

series ordinal

2

1 reference

18 August 2017

1 March 2008

1 reference

Journal of Gastroenterology and Hepatology

18 August 2017

1 reference

18 August 2017

23 Suppl 1

1 reference

18 August 2017

S112-8

1 reference

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Liver: An organ with predominant innate immunity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

The roles of innate immune cells in liver injury and regeneration.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

The hepatitis C virus life cycle as a target for new antiviral therapies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

The effects of HCV infection and management on health-related quality of life

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

The complement system in liver diseases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Cellular and molecular mechanisms of liver tolerance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Global challenges in liver disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Pattern recognition receptors: a contemporary view on liver diseases.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Toll-like receptor signaling in the liver

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Molecular mechanisms of alcohol-induced hepatic fibrosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

The liver as an immunological organ

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

To be or not to be NKT: natural killer T cells in the liver.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Hepatitis C and alcohol: interactions, outcomes, and implications

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Alcohol use and hepatitis C.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Innate immune recognition

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Treatment of chronic hepatitis C virus infection in patients with cirrhosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Innate and adaptive lymphoid cells in the human liver

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Critical contribution of liver natural killer T cells to a murine model of hepatitis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.

27 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Mannose-binding lectin in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Long-term alcohol exposure changes sensitivity of rat Kupffer cells to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Ethanol suppresses NK cell activation by polyinosinic-polycytidylic acid (poly I:C) in female B6C3F1 mice: role of endogenous corticosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Chronic ethanol inhibits NK cell cytolytic activity: role of opioid peptide beta-endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Opioid antagonist naltrexone disrupts feedback interaction between mu and delta opioid receptors in splenocytes to prevent alcohol inhibition of NK cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Complement C3 contributes to ethanol-induced liver steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.05274.X

Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737176

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

3 September 2018

1 reference

12 December 2020

Alcohol and hepatitis C

1 reference

12 December 2020

Food proteins and gut mucosal barrier. IV. Effects of acute and chronic ethanol administration on handling and uptake of bovine serum albumin by rat small intestine

1 reference

12 December 2020

Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis

1 reference

12 December 2020

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

1 reference

12 December 2020

Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism

1 reference

12 December 2020

Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver

1 reference

12 December 2020

Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis

1 reference

12 December 2020

Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells

1 reference

12 December 2020

Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis

1 reference

12 December 2020

10.1111/J.1440-1746.2007.05274.X

Identifiers

DOI

1 reference

18 August 2017

1 reference

PMC publication ID

2737176

18 August 2017

PubMed publication ID

18336653

1 reference

PMC publication ID

2737176